← Leaderboards
Delphi Chatterjee
Colorado State University-Fort Collins
$5,062,028
Attributed
$5,062,028
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $609K · FY2005–21$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$5,062,028 · 5
By mechanism
R01$3,864,418 · 2
R21$627,059 · 2
P01$570,551 · 1
Top collaborators
No co-investigators on record.
Most similar at Colorado State University-Fort Collins
Same institution · by research overlap
- Patrick Joseph Brennan$8,803,724
- Michael R McNeil$4,500,958
- James H Naismith$554,601
Others in their field
Top investigators on “Cell Wall”
- Mary L. Disis · University Of Washington$40,406,989
- Jan E Schnitzer · Sidney Kimmel Cancer Center$19,612,834
- Zahi A. Fayad · Mount Sinai School Of Medicine Of Nyu$19,022,680
- Frances E. Lund · University Of Alabama At Birmingham$18,684,130
- William Robert Taylor · Emory University$18,682,463
- Arturo Alvarez-Buylla · Rockefeller University$18,341,361
Research focus
Cell WallMycobacterium TuberculosisPropertyProteinsBaseLipoarabinomannanPharmaceutical PreparationsMannansTuberculosisInterestGalactansIn VivoDetergentsCell EnvelopeAdultCollaborationsAnabolismDesignDrug Resistance In TuberculosisEngineeringGoldGrowthStructureTuberculosis Drugs
Grant awards (19)
Validation of urine/serum LAM in HIV/nonHIV TB suspects and POC Test Development$558,656
R01 · FY2021 · AI · contact PI
Validation of urine/serum LAM in HIV/nonHIV TB suspects and POC Test Development$591,412
R01 · FY2020 · AI · contact PI
Validation of urine/serum LAM in HIV/nonHIV TB suspects and POC Test Development$590,576
R01 · FY2019 · AI · contact PI
Validation of urine/serum LAM in HIV/nonHIV TB suspects and POC Test Development$608,952
R01 · FY2018 · AI · contact PI
Biosynthesis and transbilayer flipping of mycobacterial PIM glycolipids$204,260
R21 · FY2009 · AI · contact PI
Structure of LAM in Relation to Biology and Biosynthesis$236,030
R01 · FY2008 · AI · contact PI
Biosynthesis and transbilayer flipping of mycobacterial PIM glycolipids$178,359
R21 · FY2008 · AI · contact PI
Core--Anti Multi Drug Resistant-Tuberculosis MICs & Cytotoxicity of New Compounds$113,321
P01 · FY2008 · AI · contact PI
Structure of LAM in Relation to Biology and Biosynthesis$240,601
R01 · FY2007 · AI · contact PI
Core--Anti Multi Drug Resistant-Tuberculosis MICs & Cytotoxicity of New Compounds$109,768
P01 · FY2007 · AI · contact PI
Structure of LAM in Relation to Biology and Biosynthesis$247,788
R01 · FY2006 · AI · contact PI
Anti MDR-TB MICs and Cytotoxicity of New Compounds$112,661
P01 · FY2006 · AI · contact PI
Structure of LAM in Relation to Biology and Biosynthesis$253,750
R01 · FY2005 · AI
Anti MDR-TB MICs and Cytotoxicity of New Compounds$109,645
P01 · FY2005 · AI
Structure of LAM in Relation to Biology and Biosynthesis$169,167
R01 · FY2004 · AI
Anti MDR-TB MICs and Cytotoxicity of New Compounds$125,156
P01 · FY2004 · AI
Structure of LAM in Relation to Biology and Biosynthesis$244,440
R21 · FY2002 · AI
TB LAM AND AG--STRUCTURES CORRELATED WITH BIOLOGY$186,458
R01 · FY2001 · AI
TB LAM AND AG--STRUCTURES CORRELATED WITH BIOLOGY$181,028
R01 · FY2000 · AI